Applying Emerging AI and Machine Learning Tools to Find Equitable Solutions to Scientific Discovery

As artificial intelligence (AI) and machine learning (ML) applications and usage continue to evolve and become more commonplace, the ever-increasing adoption of this technology is creating a tidal wave of conversation and questions about the ramifications it will have across multiple industries.

Join us for our inaugural episode of The Nucleus by Regeneron, hosted by Jeffrey Reid, Vice President, Chief Data Officer, Regeneron Genetics Center (RGC), in conversation with Daphne Koller, Founder and CEO, insitro to examine how AI and ML are already being applied to tackle some of the most pressing challenges in science and the many ways they will continue to transform the industry for years to come. From accelerating drug discovery to personalizing medical treatments, this episode will share insights on the many ways AI and ML are driving progress in the field and highlight the importance of human oversight of the application of these technologies to ensure they are providing equitable and ethical outputs.